Related Experiment Videos
DIC secondary to acute pancreatitis
1Division of Hematology/Oncology and Department of Clinical Pharmacology/Toxicology, University of Alabama at Birmingham (UAB), 263 Wallace Tumor Institute, 1824 6th Avenue South, Birmingham, AL 35294, USA. wasif.saif@ccc.uab.edu
Clinical and Laboratory Haematology
|July 29, 2005
Summary
Acute pancreatitis can cause serious blood clotting issues, including disseminated intravascular coagulopathy (DIC). Early recognition of these hematological abnormalities is crucial for patient management.
Area of Science:
- Hematology
- Gastroenterology
- Critical Care Medicine
Background:
- Acute pancreatitis is associated with various hematological abnormalities.
- Coagulation factor abnormalities, consistent with disseminated intravascular coagulopathy (DIC), have been observed in pancreatitis patients.
Observation:
- A case of a 33-year-old female with acute pancreatitis presenting with epistaxis and abnormal coagulation parameters is detailed.
- The patient exhibited elevated D-dimers and low fibrinogen, indicative of DIC, which resolved with pancreatitis treatment.
Findings:
- Coagulation abnormalities, including DIC, are encountered in acute pancreatitis.
- These hemostatic derangements may stem from intravascular consumption of coagulation factors due to pancreatic enzymes or vascular injury.
Implications:
- Awareness of hematological complications, particularly DIC, is vital for clinicians managing acute pancreatitis.
- Prompt recognition and management of these clotting abnormalities can improve patient outcomes.